ABCL: AbCellera Biologics Inc. Stock

by  •  • Comments Off on ABCL: AbCellera Biologics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 612.36
Enterprise Value ($M) 453.10
Book Value ($M) 1,022.98
Book Value / Share 3.43
Price / Book 0.60
NCAV ($M) 443.75
NCAV / Share 1.49
Price / NCAV 1.38

Profitability (mra)
Return on Invested Capital (ROIC) -0.15
Return on Assets (ROA) -0.11
Return on Equity (ROE) -0.15

Liquidity (mrq)
Quick Ratio 10.15
Current Ratio 10.15

Balance Sheet (mrq) ($M)
Current Assets 764.98
Assets 1,344.21
Liabilities 321.23
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 28.83
Operating Income -282.77
Net Income -162.86

Cash Flow Statement (mra) ($M)
Cash From Operations -108.56
Cash from Investing 121.41
Cash from Financing 12.77

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Baker Bros. Advisors Lp 9.30 20.15
10-09 13G/A Baillie Gifford & Co 4.40 -46.37

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-14 1,197,083 6,417,062 18.65
2025-05-13 2,392,426 16,756,090 14.28
2025-05-12 851,166 4,195,147 20.29
2025-05-09 728,860 3,817,675 19.09

(click for more detail)

Similar Companies
ABOS – Acumen Pharmaceuticals, Inc. ABUS – Arbutus Biopharma Corporation


Financial data and stock pages provided by
Fintel.io

Finpedia: AbCellera Biologics